Calitor Sciences, LLC;Sunshine Lake Pharma Co., Ltd.
发明人:
申请号:
EP15769715.2
公开号:
EP3122730A4
申请日:
2015.03.27
申请国别(地区):
EP
年份:
2017
代理人:
摘要:
The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof useful in preventing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.